NOLUS: a predictive model to identify Basal-like and HER2-enriched intrinsic subtypes based on estrogen receptor (ER), progesterone receptor (PR) and Ki67 immunohistochemistry (IHC) in hormone receptor-positive/HER2-negative (HR+/HER2–) breast cancer (BC). (April 2018) - Pascual, T.; Martín, M.; Pare, L.; Alba, E.; Rodríguez-Lescure, A.; Perrone, G.; Cortés, J.; Morales, S.; Lluch, A.; Urruticoechea, A.; Galván, P.; Rodríguez, A.; et al.